---
figid: PMC9069408__gr4
figtitle: 'Impairment of the autophagy–lysosomal pathway in Alzheimer''s diseases:
  Pathogenic mechanisms and therapeutic potential'
organisms:
- Saccharomyces cerevisiae
- Panax ginseng
- Arachis hypogaea
- Hydrastis canadensis
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Mus musculus
pmcid: PMC9069408
filename: gr4.jpg
figlink: /pmc/articles/PMC9069408/figure/fig4/
number: F4
caption: A vicious cycle between the autophagy–lysosomal dysfunction and accumulation
  of APP/APP metabolites and MAPT/tau aggregates in AD. The impairment of autophagy–lysosome
  pathway (such as genetic factor) in AD compromises the degradation and subsequent
  accumulation of APP, APP-CTFβ, Aβ, and MAPT/tau aggregates, which further induces
  the impairment of autophagy–lysosome pathway (e.g., inhibit autophagosome formation,
  and autophagosome–lysosomes fusion). Thus, a vicious cycle of autophagy–lysosomal
  dysfunction and accumulation of APP/APP metabolites and MAPT/tau aggregates are
  formed, which may finally contribute to neurodegeneration.
papertitle: 'Impairment of the autophagy–lysosomal pathway in Alzheimer''s diseases:
  Pathogenic mechanisms and therapeutic potential.'
reftext: Wei Zhang, et al. Acta Pharm Sin B. 2022 Mar;12(3):1019-1040.
year: '2022'
doi: 10.1016/j.apsb.2022.01.008
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: Alzheimer's disease (AD) | Amyloid beta (Aβ) peptides | MAPT/tau | Autophagy–lysosomal
  pathway | Autophagy enhancers | Autophagy | Mitophagy | Neurodegenerative diseases
automl_pathway: 0.7673118
figid_alias: PMC9069408__F4
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC9069408__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9069408__gr4.html
  '@type': Dataset
  description: A vicious cycle between the autophagy–lysosomal dysfunction and accumulation
    of APP/APP metabolites and MAPT/tau aggregates in AD. The impairment of autophagy–lysosome
    pathway (such as genetic factor) in AD compromises the degradation and subsequent
    accumulation of APP, APP-CTFβ, Aβ, and MAPT/tau aggregates, which further induces
    the impairment of autophagy–lysosome pathway (e.g., inhibit autophagosome formation,
    and autophagosome–lysosomes fusion). Thus, a vicious cycle of autophagy–lysosomal
    dysfunction and accumulation of APP/APP metabolites and MAPT/tau aggregates are
    formed, which may finally contribute to neurodegeneration.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - app
  - Appl
  - ApepP
  - APP-BP1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ab
  - tau
  - CycE
  - cyc
  - App
  - H2-Ab1
  - Mapt
  - Csnk1e
  - APP
  - SUCLA2
  - MAPT
---
